検索結果

adquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designation to the in-house developed compound having the development code SJP-0008 ...

Quality Policies | About Senju | SENJU Pharmaceutical

We will set the following "Quality Policies" and continue to be a "Good Company" by encouraging cooperation among all employees and providing high-quality products for "realiz...

CEO Message | About Senju | SENJU Pharmaceutical

been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&D capabilities.Throughout our history, we...

Management Policy | About Senju | SENJU Pharmaceutical

valuable for society, we are committed to pursuing happiness for all people associated with Senju rather than just becoming a “big company” that pursues only greater growth and increased sales. Action...

Overseas Activities | SENJU Pharmaceutical

nd pharmaceutical development have no borders. We engage in international activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the era o...